IP Verse

Amgen Technology Ireland Unlimited competitive analysis

Loading summary...

Latest oppositions filed by Amgen Technology Ireland Unlimited

Explore patent oppositions filed by Amgen Technology Ireland Unlimited against competitors, revealing strategic technology disputes and market positioning.

Last updated on: Oct 30, 2025
Patent NumberTitleApplicantOpposition Date

Get instant updates on new opposition filings by the company

EP3167888
Treatment Of Paroxysmal Nocturnal Hemoglobinuria Patients By An Inhibitor Of ComplementALEXION PHARMACEUTICALSOct 28, 2024
EP2894165
Methods And Compositions For Treating Complement-Associated DisordersALEXION PHARMACEUTICALSMay 17, 2023

Latest publications and patents of Amgen Technology Ireland Unlimited New

Explore the latest publications and patents granted to Amgen Technology Ireland Unlimited, showcasing their recent innovations and technological advancements.

Latest PTAB cases involving Amgen Technology Ireland Unlimited

Discover the latest PTAB cases involving Amgen Technology Ireland Unlimited, highlighting their recent legal challenges and patent disputes.

Peer Comparison New

IP litigation analysis comparing Amgen Technology Ireland Unlimited with top 3 competitors. Includes complete PTAB case data and opposition data from 2018 onwards.

Last updated on: Oct 30, 2025
CompanyOppositions FiledOppositions FacedPTAB Cases FiledPTAB Cases Faced
AMGEN TECHNOLOGY IRELAND UNLIMITED2 - - -
ALEXION PHARMACEUTICALS38 - 8